High frequencies thresholds and otoacoustics emissions in patients with sickle cell anemia

Authors

DOI:

https://doi.org/10.33448/rsd-v10i4.13627

Keywords:

Sickle cell anemia; Hearing; Audiometry; Hearing loss.

Abstract

Objective: To verify auditory thresholds at conventional and high frequencies and the presence of distortion product otoacoustic emissions in sickle cell patients, analyzing the age group variable. Method: Observational, prospective, analytical cohort for diagnostic purposes. Conventional audiometry, high frequency audiometry and distortion product otoacoustic emissions were performed in patients with the disease. Results: 38 patients were evaluated, 16 (42.1%) in the age group from 7 to 20 years old and 22 (57.9%), from 21 to 35 years old. Hearing impairment in conventional audiometry was 6.3% in the age group of 7 to 20 years and 13, 6%, between 21 and 35 years. There was no statistically significant difference between the age groups (p = 0.624). In high frequency audiometry, changes in 25% of children and adolescents and in 68.2% of adults. Adults had greater hearing loss (p = 0.021). There was no significant difference when comparing the distortion product otoacoustic emissions signal / noise ratio measurements between the ears, both in the total sample and by age group (p> 0.05). There was no significant association between the results of the distortion product otoacoustic emissions changes and hearing loss at ultra-high frequencies both in children and adolescents (p = 0.250) and in adults (p = 0.121). When comparing the sensitivity of the high frequency audiometry and distortion product otoacoustic emissions exams, there was a significant difference between them only in adults (p = 0.004). Conclusions: Adults with a longer duration of exposure to the disease showed increased thresholds in high frequency audiometry, as well as changes in distortion product otoacoustic emissions.

References

Burch-Sims, G. P., & Matlock, V. R. (2005). Hearing loss and auditory function in sickle cell disease. Journal of Communication Disorders, 38, 321-329.

Farrel, N. A., Landry, A. M., Yee, E., Leu, R. M., & Goudy, S. L. (2019). Sensorineural hearing loss in children with sickle cell disease. International Journal of Pediatric Otorhinolaryngology, 118, 110–114.

Geyer, L. B., Menna Barreto, S. S., Weigert, L. L., & Teixeira, A. R. (2015). High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients. Brazilian Journal Otorhinolaryngology, 81(6), 589-597.

Kegele, J. et al. Otoacoustic emission testing in Ghanaian children with sickle cell disease. (2015). Tropical Medicine and International Health, 20 (9), 1209-1212.

Kemp, D.T. (2002). Otoacoustic emissions, their origin in cochlear function, and use. British Medical Bulletim, 63(1), 223–41.

Köche, J. C. (2011). Fundamentos da metodologia científica: teoria da ciência e iniciação à pesquisa: Editora Vozes.

Lago, M. R. R. et al. (2018). Sensorineural hearing loss in children with sicklecell anemia and its association with endotelial dysfunction. Hematology, 23(10), 848-855.

Olajuyin, A. O., Olatunya, O. S., Adegbiji, A. W., Oyenibi, A. S., & Faboya, A. O. (2018). Otological burdens of Nigerian children with sickle cell disease. International Journal of Pediatric Otorhinolaryngology, 107, 1–5.

Oliveira, N. et al. (2009). Oxigenoterapia hiperbárica no tratamento da surdez súbita idiopática. Revista Portuguesa de Otorrinolaringologia e Cirurgia Cérvico-Facial, 47(4), 197-202.

Potoka, K. P., & Gladwin, M. T. (2015). Vasculopathy and pulmonary hypertension in sickle cell disease. American Journal of Physiology-Lung Cellular and Molecular Physiology, 308(4), L314-324.

Psaltakos, V. et al. (2013). Cochlear dysfunction. in. patients with acute hypothyroidism. European Archives of Otorhinolaryngology, 270(11), 2839-2848.

Rodrigues, P. A. M. (2017). Surdez súbita e oxigenoterapia hiperbárica. Dissertação (Mestrado Integrado em Medicina), Universidade de Lisboa, Lisboa, Portugal.

Sarac, E. T., Boke, B., & Okuyucu, S. (2018). Evaluation of Hearing and Balance Functions of Patients with Sickle Cell Anemia. Audiology and Neurotology, 23,122–125.

Silva, L. P. A., Nova, C. V., & Lucena, R. (2012). Anemia falciforme e surdez infanto-juvenil: revisão da literatura. Brazilian Journal of Otorhinolaryngology, 78(1), 126-131.

Silva, P. B., Fiorini, A. C., & Azevedo, M. F. (2017). Estudo das emissões otoacústicas em indivíduos expostos a ruído de bateria universitária. Revista CEFAC, 19(5), 645-653.

Stuart, A., & Preast, J. L. (2012). Contralateral suppression of transient-evoked otoacoustic emissions in children with sickle cell disease. Ear and Hearing, 33(3), 421-429.

Stuart, A., & Smith, M. R. (2019). The emergence and prevalence of hearing loss in children with homozygous sickle cell disease. International Journal of Pediatric Otorhinolaryngology, 123, 69–74.

Weigert, L. L., Piltcher, O. B., Procianoy, E. F. A., Buss, C. H., & Menna-Barreto, S. S. (2013). Avaliação do uso da audiometria em frequências ultra-altas em pacientes submetidos ao uso de ototóxicos. Brasília Medica, 50, 264-73.

Published

28/03/2021

How to Cite

WEIGERT, L. L.; TEIXEIRA, A. R.; GEYER, L. B.; BITTAR, C. . M.; SCHWEIGER, C.; SEIMETZ, B. M.; RUSCHEL, N. L.; LIMA, J. M.; BARRETO, S. S. M. . High frequencies thresholds and otoacoustics emissions in patients with sickle cell anemia. Research, Society and Development, [S. l.], v. 10, n. 4, p. e0510413627, 2021. DOI: 10.33448/rsd-v10i4.13627. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/13627. Acesso em: 11 apr. 2021.

Issue

Section

Health Sciences